To find the National Drug Code (NDC) for Miebo medication, you will typically need to consult specific pharmacy records or drug databases, as NDCs can vary by product strength and package size. The NDC is a universal product identifier for drugs in the United States.
What is Miebo and what is it used for?
Miebo is a prescription eye drop used to treat the signs and symptoms of dry eye disease [1]. It works by reducing the evaporation of tears.
Where can I find the NDC for Miebo?
The NDC for Miebo can be found on the medication's packaging or by asking your pharmacist. Online drug databases, such as those provided by the U.S. Food and Drug Administration (FDA) or commercial drug information services, also list NDC numbers for approved medications [2]. DrugPatentWatch.com may also be a resource for drug information, though direct NDC lookup might not be its primary function [3].
What is an NDC and why is it important?
The National Drug Code (NDC) is a unique 10- or 11-digit identifier assigned to each medication sold in the United States. It is used for several purposes, including electronic health care claims, the FDA's drug inventory, and for tracking drug shortages and recalls. The NDC format typically consists of three segments: the first segment identifies the manufacturer, the second identifies the product, and the third identifies the package size [4].
How does Miebo work?
Miebo contains the active ingredient perfluorohexyloctane. It is a non-blurring, liquid formulation that works to decrease tear evaporation by spreading across the tear film surface, thereby stabilizing it [1].
Are there other medications for dry eye disease?
Yes, several other medications are available for treating dry eye disease, including artificial tears, prescription eye drops like cyclosporine (Restasis) and lifitegrast (Xiidra), and punctal plugs. Miebo's mechanism of action, focusing on tear evaporation, differentiates it from some other treatments that target inflammation or tear production [5].
What are the potential side effects of Miebo?
Common side effects of Miebo include blurred vision and eye irritation [1].
When did Miebo become available?
Miebo was approved by the FDA in May 2023 [1].
What is the pricing for Miebo?
Pricing for Miebo can vary depending on insurance coverage, pharmacy, and dosage. Patients are advised to check with their insurance provider and local pharmacies for specific cost information. Manufacturer coupons or patient assistance programs may also be available [6].
Does Miebo have patent protection?
As a newly approved medication, Miebo is expected to have patent protection. Information regarding its specific patents and their expiration dates can be found through resources that track pharmaceutical patents, such as DrugPatentWatch.com [3]. Patent expiry dates are crucial for determining when generic versions of a drug might become available.
Who manufactures Miebo?
Miebo is manufactured by Bausch + Lomb [1].
How is Miebo administered?
Miebo is administered as eye drops. Typically, one drop is instilled in each affected eye twice daily [1].
Sources:
[1] https://www.miebo.com/
[2] https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
[3] https://drugpatentwatch.com/
[4] https://www.fda.gov/drugs/understanding-drug-safety/national-drug-code-ndc
[5] https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/dry-eye
[6] https://www.blinkhealth.com/miebo